The Effect of High Poly Unsaturated Fatty Acid (PUFA) Dietary Supplementation on Inflammatory Status of Patients with Advanced Cervical Cancer on Radiation Treatment.

AIM to identify the effect of high-PUFA dietary supplementation on inflammatory status of patients with advanced cervical cancer. METHODS a randomized double-blind clinical trial was conducted in patients with advanced cervical cancer who had undergone external radiation therapy at Department of Radiotherapy, Cipto Mangunkusumo Hospital, Jakarta, between April 2013 and April 2014. The inflammatory status was evaluated based on serum prostaglandin E2 (PGE2) levels using ELISA method. The dietary supplementation was isocaloric, isoprotein and contained PUFA with a ratio of -6: -3 fatty acid = 1.27:1 and supplementation without PUFA. Data were analyzed with statistical tests, including Shapiro-Wilk test, independent T-test and Mann-Whitney test. RESULTS there was statistically no significant difference on PGE2 level between treatment and control groups (p=0.127). However, there was clinically significant difference, in which the treatment group had reduced PGE2 level by 8.9%; while the control group had increased level by 28.1%. CONCLUSION dietary supplementation enriched with PUFA can reduce inflammatory status in patients with advanced cervical cancer. Reduced PGE2 level will lower the survival of cancer cells; therefore dietary supplementation enriched with PUFA with a ratio of -6 : -3 fatty acid = 1.27 : 1 along with radiation therapy may improve tumor response to radiation.

[1]  R. Gunawan.  Acute Toxicity and Outcomes of Radiation Alone Versus Concurrent Chemoradiation for Locoregional Advanced Stage Cervical Cancer , 2016 .

[2]  S. So,et al.  Screening and identification of dietary oils and unsaturated fatty acids in inhibiting inflammatory prostaglandin E2 signaling in fat stromal cells , 2012, BMC Complementary and Alternative Medicine.

[3]  R. Murphy,et al.  n-3 polyunsaturated fatty acids: the potential role for supplementation in cancer , 2012, Current opinion in clinical nutrition and metabolic care.

[4]  Y. Goh,et al.  Effects of varying levels of n-6:n-3 fatty acid ratio on plasma fatty acid composition and prostanoid synthesis in pregnant rats , 2010 .

[5]  M. F. Aziz.  Gynecological cancer in Indonesia. , 2009, Journal of gynecologic oncology.

[6]  M. Sawyer,et al.  The potential for treatment with dietary long-chain polyunsaturated n-3 fatty acids during chemotherapy. , 2008, The Journal of nutritional biochemistry.

[7]  S. Stehr,et al.  Omega-3 fatty acid effects on biochemical indices following cancer surgery. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[8]  N. Seeram,et al.  Effect of Altering Dietary ω-6/ω-3 Fatty Acid Ratios on Prostate Cancer Membrane Composition, Cyclooxygenase-2, and Prostaglandin E2 , 2006, Clinical Cancer Research.

[9]  R. DuBois,et al.  PROSTAGLANDINS AND CANCER , 2005, Gut.

[10]  Magnus Ingelman-Sundberg,et al.  Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. , 2004, The American journal of clinical nutrition.

[11]  A. Simopoulos.  Omega-3 Fatty Acids in Inflammation and Autoimmune Diseases , 2002, Journal of the American College of Nutrition.

[12]  W. Hardman.  Omega-3 fatty acids to augment cancer therapy. , 2002, The Journal of nutrition.

[13]  C. Suh,et al.  Overexpression of cyclooxygenase‐2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy , 2002, Cancer.